Apnimed, Inc.
APMD
IPO
$24.89
-$3.05-10.92%
NASDAQ
| 03/31/2026 | |||||
|---|---|---|---|---|---|
| Revenue | 2,608.85% | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | 2,608.85% | ||||
| Cost of Revenue | 64.01% | ||||
| Gross Profit | 4,456.45% | ||||
| SG&A Expenses | 18.94% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | -44.55% | ||||
| Operating Income | 350.97% | ||||
| Income Before Tax | 363.76% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | 363.76% | ||||
| Earnings from Discontinued Operations | -35.06% | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | 336.40% | ||||
| EBIT | 350.97% | ||||
| EBITDA | 351.06% | ||||
| EPS Basic | 333.75% | ||||
| Normalized Basic EPS | 352.98% | ||||
| EPS Diluted | 128.59% | ||||
| Normalized Diluted EPS | 131.94% | ||||
| Average Basic Shares Outstanding | 1.13% | ||||
| Average Diluted Shares Outstanding | 701.05% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||